Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Liver and artificial liver]

R A Chamuleau1

  • 1Afd. Maag-, Darm- en Leverziekten, Academisch Medisch Centrum/Universiteit van Amsterdam.

Nederlands Tijdschrift Voor Geneeskunde
|September 30, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect and side-effects of alpha interferon treatment in haemophilia patients with chronic hepatitis C.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirin.

Journal of gastroenterology·2001
Same author

Extrahepatic portal vein thrombosis: aetiology and determinants of survival.

Gut·2001
Same author

Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration.

The Journal of biological chemistry·2001
Same author

Functional evaluation of the AMC-BAL to be employed in a multicentric clinical trial for acute liver failure.

Transplantation proceedings·2001
Same author

Sustained virological response in chronic hepatitis C patients after a 6- and a 36-month interferon-alpha2b treatment schedule: a multicenter, randomized, controlled study.

Scandinavian journal of gastroenterology·2001
Same journal

[Insulin intoxications caused by falsified semaglutide].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[Professional skepticism in medical research].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[Improving mobility in painful osteoarthritis].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[The effectiveness and costs of the Back At work After Surgery (BAAS) work-integrated care pathway on return to work for patients receiving knee arthroplasty].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[The rise of genetic therapies: urgent moral and societal questions].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[A man with a wound on his elbow].

Nederlands tijdschrift voor geneeskunde·2026
See all related articles

Bioartificial livers offer a temporary solution for severe liver failure, bridging the gap to transplantation. Current research focuses on porcine hepatocytes, with clinical trials showing promise but needing further controlled studies.

Area of Science:

  • Hepatology
  • Biomedical Engineering
  • Regenerative Medicine

Context:

  • Fulminant hepatic failure necessitates temporary liver support.
  • Orthotopic liver transplantation has limitations.
  • Existing non-biological artificial livers have shown limited success.

Purpose:

  • To develop an effective and safe artificial liver to bridge patients to liver transplantation or regeneration.
  • To evaluate the efficacy and safety of bioartificial liver devices in patients with severe liver failure.

Summary:

  • Bioartificial livers utilize porcine hepatocytes or human hepatoblastoma cells within semipermeable hollow fibers.
  • These devices are connected extracorporeally for approximately 6 hours.
  • Phase I trials in ~40 patients with severe liver failure reported no significant adverse effects.

Related Experiment Videos

Impact:

  • Bioartificial livers show potential to increase patient survival in liver failure.
  • Further controlled studies are crucial to establish clinical efficacy.
  • Porcine hepatocytes are currently the preferred cell source, pending prevention of pathogen transmission.